ArticleScientific reports2026
Sequential boundary tracking via reinforcement learning for overlapping cell resolution in sickle cell imaging.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Sickle cell disease requires rapid, accurate diagnostic screening to facilitate early therapeutic actions with potential life-saving impact. Unfortunately, traditional manual microscopy screening is heavily affected by high rates of human error, long processing delays, and detection variability, which are especially pronounced when identifying truly challenging microscopic fields of view, such as those consisting of clusters of overlapping red blood cells. These diagnostic delays result in poor patient outcomes, particularly in resource-limited settings where specialized healthcare providers are scarce. Highly precise automated tracking solutions are thus essential to ensure diagnostic fairness and reliability. To address these challenges, we introduce a general end-to-end hybrid in which feature extraction is based on deep localized features and decision-making is performed by sequential RL. The method is based on a dual-stage pipeline: a bespoke U-Net architecture first separates individual cells within complex, overlapping cell bunches, and afterward, a Q-learning agent that finds optimized sequential tracking paths on the coordinate grid matrices maps the cells to final labels. Extensive experimental results on the public Kaggle dataset show that the segmentation module achieves a high-fidelity dice similarity coefficient of 95.51%, and the proposed integrated RL pathfinder improves the final classification results, achieving an overall accuracy of 98.00%. Our solution achieves a +16:60% absolute diagnostic improvement over a traditional single CNN classifier (81:40%), demonstrating that the proposed framework is robust, has novel methodological characteristics, and is clinically viable for fully automated hematological screening.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.